M. Rasilainen

Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.

A. Paetau, J. Jääskeläinen, M. Kallio, 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.

A. Paetau, S. Savolainen, J. Jääskeläinen, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short Communication Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy

A. Paetau, S. Savolainen, H. Minn, 2004 .

Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway.

J. Jääskeläinen, M. Kallio, J. Laakso, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.

A. Häkkinen, N. Lundbom, S. Savolainen, 2005, European journal of radiology.